Screener
Spyre Therapeutics, Inc. SYRE Total Equity
Total Equity at other companies
Other financials
Where this comes from
Reported directly by Spyre Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:StockholdersEquity.
The source filing: Spyre Therapeutics, Inc.’s 10-Q, filed May 5, 2026.
- Filed
- May 5, 2026, 8:00 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001636282-26-000050
| Line item | March 31,2026 | December 31,2025 |
|---|---|---|
| Series B non-voting convertible preferred stock, $0.0001 par value; 271,625 shares authorized and 16,667 shares issued and outstanding as of March 31, 2026 and December 31, 2025. | 9,395 | 9,395 |
| Preferred stock, $0.0001 par value; 8,642,034 shares authorized as of March 31, 2026 and December 31, 2025; no shares issued and outstanding as of March 31, 2026 and December 31, 2025. | — | — |
| Common stock, $0.0001 par value; 400,000,000 shares authorized as of March 31, 2026 and December 31, 2025; 78,839,858 shares and 78,189,811 shares issued and outstanding as of March 31, 2026 and December 31, 2025, respectively. | 15 | 15 |
| Additional paid-in capital | 1,712,383 | 1,686,167 |
| Accumulated other comprehensive (loss) income | (767) | 869 |
| Accumulated deficit | (1,196,640) | (1,127,635) |
| TOTAL STOCKHOLDERS’ EQUITY | 670,811 | 715,236 |
| TOTAL LIABILITIES, CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS’ EQUITY | $763,953 | $777,781 |
Item 1. Financial Statements (Unaudited).
FAQ
- What is Spyre Therapeutics, Inc.'s total equity?
- Spyre Therapeutics, Inc. (SYRE) reported total equity of $670.81M in Q1 2026.
- How has Spyre Therapeutics, Inc.'s total equity changed year-over-year?
- Spyre Therapeutics, Inc.'s total equity increased by 39.0% year-over-year, from $482.61M to $670.81M.
- What is the long-term trend for Spyre Therapeutics, Inc.'s total equity?
- Over 5 years (2020 to 2025), Spyre Therapeutics, Inc.'s total equity has grown at a 38.6% compound annual growth rate (CAGR), from $139.83M to $715.24M.
- What does total equity mean?
- Net assets attributable to shareholders — total assets minus total liabilities. Represents the book value of shareholders' ownership claim.
Ask your AI about Spyre Therapeutics, Inc.'s total equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude